Sort
85,873 grants matching “alzheimers”
NEURONAL &VASCULAR PATHOBIOLOGY IN ALZHEIMER'S DISEASE
$1,453,356Nathan S. Kline Institute For Psych Res · P01 · FY2004 · AG
The Emory Alzheimer's Disease Center
$1,453,327Allan I Levey · Emory University · P50 · FY2008 · AG
MOLECULAR SUBSTRATES OF AGING AND NEURON DEATH
$1,453,112University Of Pennsylvania · P01 · FY2002 · AG
Influence of thalamic IL-33 signaling in aging-associated exacerbation of cognitive impairment after brain injury via microglial dysfunction and tau pathology
$1,452,959Shinichi Kano · University Of Alabama At Birmingham · RF1 · FY2022 · AG
Core B Clinical
$1,452,762Marilyn S Albert · Johns Hopkins University · U19 · FY2019 · AG
Multimodal Imaging: Genetic and Environmental Effects in Neuropsychiatry
$1,452,712Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2019 · MH
The impact of metals and polygenic risk on multiomics, brain aging, and ADRD outcomes
$1,452,584Justin Adam Colacino · University Of Michigan At Ann Arbor · U01 · FY2025 · AG
DNA Damage and Neurodegeneration in the Aging Brain
$1,452,528Bruce A Yankner · Harvard Medical School · P01 · FY2006 · AG
Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD
$1,452,237James G. Moe · Oligomerix, Inc · R44 · FY2020 · AG
Genetic models of sporadic Alzheimers Disease in the marmoset
$1,452,175Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2024 · AG
Core B: Alzheimer's Disease Down Syndrome Outreach Recruitment and Education (ADDORE)
$1,452,087Ann D. Cohen · University Of Pittsburgh At Pittsburgh · U19 · FY2023 · AG
Core B: Alzheimer's Disease Down Syndrome Outreach Recruitment and Education (ADDORE)
$1,452,087Ann D. Cohen · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AG
Axonal transport of endo-lysosomal organelles and presynaptic cargoes in the maintenance of axon cellular homeostasis and synaptic function
$1,451,445Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Primary Care Detection of Cognitive Impairment Leveraging Health and Consumer Technologies in Underserved Communities: The MyCog Trial
$1,451,382Michael S Wolf · Northwestern University At Chicago · U01 · FY2022 · NS
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)
$1,451,083Jacobo E. Mintzer · Medical University Of South Carolina · R01 · FY2016 · AG
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD
$1,451,070Sandeep Patil · Praxis Bioresearch, Llc · R44 · FY2021 · AG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,450,881Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Racial/Ethnic Disparities in ADRD Risk: The Impact of Social Relations
$1,450,668Toni Claudette Antonucci · University Of Michigan At Ann Arbor · R01 · FY2021 · AG
Sexual dimorphic cell type and connectivity atlases of the aging and AD mouse brains
$1,450,667Hong-Wei Dong · University Of California Los Angeles · R01 · FY2023 · AG
Bioinformatics
$1,450,563Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Protein Phosphorylation and Regulation of cytoskeleton in Neuronal System Physiology and Pathology
$1,450,279Harish C Pant · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
ROLE OF GLIA IN NEURONAL DEGENERATION
$1,449,700Linda J Van Eldik · Northwestern University At Chicago · P01 · FY2007 · AG
In-Vehicle Sensors to Detect Cognitive Change in Older Drivers
$1,449,617Ruth M. Tappen · Florida Atlantic University · R01 · FY2021 · AG
University of Florida - Mt. Sinai Medical Center AD Research Center
$1,449,508Todd E. Golde · University Of Florida · P50 · FY2016 · AG
The spectrum of cognitive impairment including Alzheimerâs Disease and Related Dementias after liver transplantation
$1,449,283Jennifer C. Lai · University Of California, San Francisco · R01 · FY2025 · AG